Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

AIMday Advanced Therapies & Regenerative Medicine - registration for academics now open

Events Innovation Research

Medical Sciences Business Development & Partnering Team are delighted to announce that the AIMday in Advanced Therapies & Regenerative Medicine is now open for registration by academics.

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? 

If you answer YES to any of the above, now is the time to register for the AIMday in Advanced Therapies & Regenerative Medicine, taking place on Wednesday 3 April at the Blavatnik School of Government. A range of companies including LIft Biosciences, Alcyomics, Oxford MEStar, Novo Nordisk, DJS Antibodies, The Electrospinning Company and Bio-Techne are registered to attend, and it will be a fantastic opportunity for researchers looking to network with industry and discuss relevant questions. To see the questions posed by these companies, please visit aimday.se/atrm-2019/questions-listing.

This years AIMday follows on from previous successful AIMdays in Ageing (2016), Microscopy (2017) and Biomedical Imaging (2018).

FREE registration for academics is now open and closes on 15 March. 

Please note, advance registration is essential. 

To register and find out more, please visit aimday.se/ATRM-2019. 

What are AIMdays?

  • AIMdays provide a platform for companies to host roundtable discussions with a group of self-selecting academics
  • Industry sets the agenda and topics for discussion
  • Academics from across multiple disciplines sign up to participate in the discussions

How does it work?

Step 1: Companies submit a question/s around the theme of the day

Step 2: Oxford’s researchers sign up to answer one or more of the questions

Step 3: One question, one hour for discussion, one group of experts

 

For additional information please contact amira.burshan@medsci.ox.ac.uk

Find out more about the work of the Business Development & Partnering Team

Similar stories

EAVI2020: The Quest for an HIV Vaccine

In this long read published to coincide with International AIDS Day, we explore how an international collaboration – of which the University of Oxford is a key partner – has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.

Smoking increases the risks of 56 diseases in Chinese adults

Smoking increases the risks of 56 diseases and kills more than one million adults in China each year from 22 different causes, according to new research published in The Lancet Public Health.

Treating mental illness with electricity marries old ideas with modern tech and understanding of the brain – podcast

Young lives under pressure as global crises hits mental health and well-being – report

The well-being and mental health of young people in low - and middle - income countries have been dramatically affected by the series of crises hitting the world. As the international community continues to struggle with the impact of COVID-19, conflict and climate change, the latest report from the Young Lives project shows a long-running upward trend in young people’s well-being has been sharply reversed alongside widespread anxiety and depression. Young people are less confident about their futures for the first time in the 20-year study.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

First evidence drug resistant bacteria can travel from gut to lung, increasing infection risks

A new Oxford University study released during World Antimicrobial Awareness Week has significant findings on how antimicrobial resistance (AMR) arises and persists. The results, published today in Nature Communications, provide the first direct evidence of AMR bacteria migrating from a patient’s gut microbiome to the lungs, increasing the risk of deadly infections.